[1] |
Grande M, Jansen FA, Blumenfeld YJ, et al. Genomic microarray in fetuses with increased nuchal translucency and normal karyotype: a systematic review and Meta-analysis[J]. Ultrasound Obstet Gynecol, 2015, 46(6): 650-658. DOI: 10.1002/uog.14880.
|
[2] |
Huang J, Poon LC, Akolekar R, et al. Is high fetal nuchal translucency associated with submicoscopic chromosomal abnormalities on array CGH?[J]. Ultrasound Obstet Gynecol, 2014, 43(6): 620-624. DOI: 10.1002/uog.13384.
|
[3] |
Vora NL, Powell B, Brandt A, et al. Prenatal exome sequencing in anomalous fetuses: new opportunities and challenges[J]. Genet Med, 2017, 19(11): 1207-1216. DOI: 10.1038/gim.2017.33.
|
[4] |
Le Lous M, Bouhanna P, Colmant C, et al. The performance of an intermediate 16th-week ultrasound scan for the follow-up of euploid fetuses with increased nuchal translucency[J]. Prenat Diagn, 2016, 36(2): 148-153. DOI: 10.1002/pd.4756.
|
[5] |
|
[6] |
Xue Y, Ankala A, Wilcox WR, et al. Solving the molecular diagnostic testing conundrum for Mendelian disorders in the era of next-generation sequencing: single-gene, gene panel, or exome/genome sequencing[J]. Genet Med, 2015, 17(6): 444-451. DOI: 10.1038/gim.2014.122.
|
[7] |
Retterer K, Juusola J, Cho MT, et al. Clinical application of whole-exome sequencing across clinical indications[J]. Genet Med, 2016, 18(7): 696-704. DOI: 10.1038/gim.2015.148.
|
[8] |
Yates CL, Monaghan KG, Copenheaver D, et al. Whole-exome sequencing on deceased fetuses with ultrasound anomalies: expanding our knowledge of genetic disease during fetal development[J]. Genet Med, 2017, 19(10): 1171-1178. DOI: 10.1038/gim.2017.31.
|
[9] |
Li X, Yao R, Tan X, et al. Molecular and phenotypic spectrum of Noonan syndrome in Chinese patients[J]. Clin Genet, 2019, 96(4): 290-299. DOI: 10.1111/cge.13588.
|
[10] |
Lord J, Mcmullan DJ, Eberhardt RY, et al. Prenatal exome sequencing analysis in fetal structural anomalies detected by ultrasonography (PAGE): a cohort study[J]. Lancet, 2019, 393(10173): 747-757. DOI: 10.1016/S0140-6736(18)31940-8.
|
[11] |
Daum H, Meiner V, Elpeleg O, et al. Fetal exome sequencing: yield and limitations in a tertiary referral center[J]. Ultrasound Obstetr Gynecol, 2019, 53(1): 80-86. DOI: 10.1002/uog.19168.
|
[12] |
Ozyuncu O, Tanacan A, Fadiloglu E, et al. Impact of increased nuchal translucency values on pregnancy outcomes: a tertiary center experience[J]. Fetal Pediatr Pathol, 2021, 40(3): 189-197. DOI: 10.1080/15513815.2019.1686787.
|
[13] |
Choy KW, Wang H, Shi M, et al. Prenatal diagnosis of fetuses with increased nuchal translucency by genome sequencing analysis[J]. Front Genet, 2019, 10: 761. DOI: 10.3389/fgene.2019.00761.
|
[14] |
|
[15] |
|
[16] |
Senat MV, Keersmaecker BD, Audibert F, et al. Pregnancy outcome in fetuses with increased nuchal translucency and normal karyotype[J]. Prenat Diagn, 2002, 22(5): 345-349. DOI: 10.1002/pd.321.
|
[17] |
Äyräs O, Eronen M, Tikkanen M, et al. Long-term neurodevelopmental outcome of children from euploid pregnancies with increased nuchal translucency in the first trimester screening[J]. Prenat Diagn, 2015, 35(4): 362-369. DOI: 10.1002/pd.4548.
|